 | • レポートコード：MRC2-11QY02576 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は片頭痛治療薬のグローバル市場について調査・分析したレポートです。種類別（トリプタン、麦角、その他）市場規模、用途別（女性、男性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別片頭痛治療薬の競争状況、市場シェア ・世界の片頭痛治療薬市場：種類別市場規模 2015年-2020年（トリプタン、麦角、その他） ・世界の片頭痛治療薬市場：種類別市場規模予測 2021年-2026年（トリプタン、麦角、その他） ・世界の片頭痛治療薬市場：用途別市場規模 2015年-2020年（女性、男性） ・世界の片頭痛治療薬市場：用途別市場規模予測 2021年-2026年（女性、男性） ・北米の片頭痛治療薬市場分析：米国、カナダ ・ヨーロッパの片頭痛治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの片頭痛治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の片頭痛治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの片頭痛治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Abbott Laboratories、Eisai、Allergan、Endo、GlaxoSmithKline、Impax Laboratories、Pfizer、AstraZeneca、Bayer、Johnson & Johnson、Merck、Teva、Amgen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Anti-Migraine Drugs Market
The global Anti-Migraine Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anti-Migraine Drugs Scope and Market Size
Anti-Migraine Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Migraine Drugs market is segmented into
Triptans
Ergots
Others
Segment by Application, the Anti-Migraine Drugs market is segmented into
Women
Men
Regional and Country-level Analysis
The Anti-Migraine Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Migraine Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Migraine Drugs Market Share Analysis
Anti-Migraine Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Migraine Drugs business, the date to enter into the Anti-Migraine Drugs market, Anti-Migraine Drugs product introduction, recent developments, etc.
The major vendors covered:
Eli Lilly
Abbott Laboratories
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen
1 Study Coverage
1.1 Anti-Migraine Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Migraine Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Migraine Drugs Market Size Growth Rate by Type
1.4.2 Triptans
1.4.3 Ergots
1.4.4 Others
1.5 Market by Application
1.5.1 Global Anti-Migraine Drugs Market Size Growth Rate by Application
1.5.2 Women
1.5.3 Men
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Migraine Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Migraine Drugs Revenue 2015-2026
2.1.2 Global Anti-Migraine Drugs Sales 2015-2026
2.2 Global Anti-Migraine Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Migraine Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Migraine Drugs Competitor Landscape by Players
3.1 Anti-Migraine Drugs Sales by Manufacturers
3.1.1 Anti-Migraine Drugs Sales by Manufacturers (2015-2020)
3.1.2 Anti-Migraine Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Migraine Drugs Revenue by Manufacturers
3.2.1 Anti-Migraine Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Migraine Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Migraine Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Migraine Drugs Revenue in 2019
3.2.5 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Migraine Drugs Price by Manufacturers
3.4 Anti-Migraine Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Migraine Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Migraine Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Migraine Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Migraine Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Migraine Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Migraine Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Migraine Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Migraine Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Migraine Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Migraine Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Migraine Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Migraine Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Migraine Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Migraine Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Migraine Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Migraine Drugs Price by Application (2015-2020)
5.2 Anti-Migraine Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Migraine Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Migraine Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Migraine Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Migraine Drugs by Country
6.1.1 North America Anti-Migraine Drugs Sales by Country
6.1.2 North America Anti-Migraine Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Migraine Drugs Market Facts & Figures by Type
6.3 North America Anti-Migraine Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Migraine Drugs by Country
7.1.1 Europe Anti-Migraine Drugs Sales by Country
7.1.2 Europe Anti-Migraine Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Migraine Drugs Market Facts & Figures by Type
7.3 Europe Anti-Migraine Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Migraine Drugs by Region
8.1.1 Asia Pacific Anti-Migraine Drugs Sales by Region
8.1.2 Asia Pacific Anti-Migraine Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Migraine Drugs by Country
9.1.1 Latin America Anti-Migraine Drugs Sales by Country
9.1.2 Latin America Anti-Migraine Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Migraine Drugs Market Facts & Figures by Type
9.3 Central & South America Anti-Migraine Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Migraine Drugs by Country
10.1.1 Middle East and Africa Anti-Migraine Drugs Sales by Country
10.1.2 Middle East and Africa Anti-Migraine Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Anti-Migraine Drugs Products Offered
11.1.5 Eli Lilly Related Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Description and Business Overview
11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Laboratories Anti-Migraine Drugs Products Offered
11.2.5 Abbott Laboratories Related Developments
11.3 Eisai
11.3.1 Eisai Corporation Information
11.3.2 Eisai Description and Business Overview
11.3.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eisai Anti-Migraine Drugs Products Offered
11.3.5 Eisai Related Developments
11.4 Allergan
11.4.1 Allergan Corporation Information
11.4.2 Allergan Description and Business Overview
11.4.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Allergan Anti-Migraine Drugs Products Offered
11.4.5 Allergan Related Developments
11.5 Endo
11.5.1 Endo Corporation Information
11.5.2 Endo Description and Business Overview
11.5.3 Endo Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Endo Anti-Migraine Drugs Products Offered
11.5.5 Endo Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Anti-Migraine Drugs Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Impax Laboratories
11.7.1 Impax Laboratories Corporation Information
11.7.2 Impax Laboratories Description and Business Overview
11.7.3 Impax Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Impax Laboratories Anti-Migraine Drugs Products Offered
11.7.5 Impax Laboratories Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Anti-Migraine Drugs Products Offered
11.8.5 Pfizer Related Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Description and Business Overview
11.9.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AstraZeneca Anti-Migraine Drugs Products Offered
11.9.5 AstraZeneca Related Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Description and Business Overview
11.10.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bayer Anti-Migraine Drugs Products Offered
11.10.5 Bayer Related Developments
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Anti-Migraine Drugs Products Offered
11.1.5 Eli Lilly Related Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Description and Business Overview
11.12.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Merck Products Offered
11.12.5 Merck Related Developments
11.13 Teva
11.13.1 Teva Corporation Information
11.13.2 Teva Description and Business Overview
11.13.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Teva Products Offered
11.13.5 Teva Related Developments
11.14 Amgen
11.14.1 Amgen Corporation Information
11.14.2 Amgen Description and Business Overview
11.14.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Amgen Products Offered
11.14.5 Amgen Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Migraine Drugs Market Estimates and Projections by Region
12.1.1 Global Anti-Migraine Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Migraine Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.2.2 North America: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Migraine Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Migraine Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Migraine Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Migraine Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Migraine Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Migraine Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Migraine Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-Migraine Drugs Market Segments
Table 2. Ranking of Global Top Anti-Migraine Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Migraine Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Triptans
Table 5. Major Manufacturers of Ergots
Table 6. Major Manufacturers of Others
Table 7. Global Anti-Migraine Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Anti-Migraine Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-Migraine Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Anti-Migraine Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-Migraine Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-Migraine Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Anti-Migraine Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Anti-Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Migraine Drugs as of 2019)
Table 16. Anti-Migraine Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Anti-Migraine Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Anti-Migraine Drugs Price (2015-2020) (USD/Pcs)
Table 19. Anti-Migraine Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Anti-Migraine Drugs Product Type
Table 21. Date of International Manufacturers Enter into Anti-Migraine Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Anti-Migraine Drugs Sales Share by Type (2015-2020)
Table 25. Global Anti-Migraine Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Anti-Migraine Drugs Revenue Share by Type (2015-2020)
Table 27. Anti-Migraine Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Anti-Migraine Drugs Sales Share by Application (2015-2020)
Table 30. North America Anti-Migraine Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Anti-Migraine Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Anti-Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Anti-Migraine Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Anti-Migraine Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Anti-Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Anti-Migraine Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Anti-Migraine Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Anti-Migraine Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Anti-Migraine Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Anti-Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Anti-Migraine Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Major Businesses
Table 72. Eli Lilly Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Eli Lilly Product
Table 74. Eli Lilly Recent Development
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Major Businesses
Table 77. Abbott Laboratories Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Abbott Laboratories Product
Table 79. Abbott Laboratories Recent Development
Table 80. Eisai Corporation Information
Table 81. Eisai Description and Major Businesses
Table 82. Eisai Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Eisai Product
Table 84. Eisai Recent Development
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Major Businesses
Table 87. Allergan Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Allergan Product
Table 89. Allergan Recent Development
Table 90. Endo Corporation Information
Table 91. Endo Description and Major Businesses
Table 92. Endo Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Endo Product
Table 94. Endo Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Major Businesses
Table 97. GlaxoSmithKline Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Impax Laboratories Corporation Information
Table 101. Impax Laboratories Description and Major Businesses
Table 102. Impax Laboratories Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Impax Laboratories Product
Table 104. Impax Laboratories Recent Development
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Pfizer Product
Table 109. Pfizer Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Major Businesses
Table 112. AstraZeneca Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. AstraZeneca Product
Table 114. AstraZeneca Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Bayer Product
Table 119. Bayer Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Major Businesses
Table 122. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Johnson & Johnson Product
Table 124. Johnson & Johnson Recent Development
Table 125. Merck Corporation Information
Table 126. Merck Description and Major Businesses
Table 127. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Merck Product
Table 129. Merck Recent Development
Table 130. Teva Corporation Information
Table 131. Teva Description and Major Businesses
Table 132. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Teva Product
Table 134. Teva Recent Development
Table 135. Amgen Corporation Information
Table 136. Amgen Description and Major Businesses
Table 137. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Amgen Product
Table 139. Amgen Recent Development
Table 140. Global Anti-Migraine Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global Anti-Migraine Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Anti-Migraine Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Anti-Migraine Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Anti-Migraine Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: Anti-Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Anti-Migraine Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: Anti-Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Anti-Migraine Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: Anti-Migraine Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Anti-Migraine Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: Anti-Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Anti-Migraine Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: Anti-Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Anti-Migraine Drugs Players
Table 158. Anti-Migraine Drugs Customers List
Table 159. Anti-Migraine Drugs Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Migraine Drugs Product Picture
Figure 2. Global Anti-Migraine Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Triptans Product Picture
Figure 4. Ergots Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Migraine Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Women
Figure 8. Men
Figure 9. Anti-Migraine Drugs Report Years Considered
Figure 10. Global Anti-Migraine Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Anti-Migraine Drugs Sales 2015-2026 (K Units)
Figure 12. Global Anti-Migraine Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Anti-Migraine Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Anti-Migraine Drugs Sales Market Share by Region in 2019
Figure 15. Global Anti-Migraine Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Anti-Migraine Drugs Revenue Market Share by Region in 2019
Figure 17. Global Anti-Migraine Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Anti-Migraine Drugs Revenue in 2019
Figure 19. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Anti-Migraine Drugs Sales Market Share by Type in 2019
Figure 22. Global Anti-Migraine Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Anti-Migraine Drugs Revenue Market Share by Type in 2019
Figure 24. Global Anti-Migraine Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Anti-Migraine Drugs Sales Market Share by Application in 2019
Figure 27. Global Anti-Migraine Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Anti-Migraine Drugs Revenue Market Share by Application in 2019
Figure 29. North America Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Anti-Migraine Drugs Sales Market Share by Country in 2019
Figure 32. North America Anti-Migraine Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Anti-Migraine Drugs Market Share by Type in 2019
Figure 38. North America Anti-Migraine Drugs Market Share by Application in 2019
Figure 39. Europe Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Anti-Migraine Drugs Sales Market Share by Country in 2019
Figure 42. Europe Anti-Migraine Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Anti-Migraine Drugs Market Share by Type in 2019
Figure 54. Europe Anti-Migraine Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region in 2019
Figure 59. China Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Anti-Migraine Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Anti-Migraine Drugs Market Share by Application in 2019
Figure 83. Latin America Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Anti-Migraine Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Anti-Migraine Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Anti-Migraine Drugs Market Share by Type in 2019
Figure 94. Latin America Anti-Migraine Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Anti-Migraine Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Anti-Migraine Drugs Market Share by Application in 2019
Figure 107. North America Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Anti-Migraine Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Anti-Migraine Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
片頭痛の世界市場（～2026年） A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound,…- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…
- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 止瀉薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Diarrheal Drugs Market The global Anti Diarrheal Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Diarrheal Drugs Scope and Market Size Anti Diarrheal Drugs market is…